Original Research
Published on 25 Mar 2022
Adverse Event Profiles of PARP Inhibitors: Analysis of Spontaneous Reports Submitted to FAERS
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.851246
- 15,013 views
- 36 citations
Type at least 3 characters
390 articles
Articles
Original Research
Published on 25 Mar 2022
Integrating Pharmacy and Registry Data Strengthens Clinical Assessments of Patient Adherence
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.869162
- 3,416 views
- 2 citations
Original Research
Published on 24 Mar 2022
Opioid Use at End-Of-Life Among Nova Scotia Patients With Cancer
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.836864
- 2,900 views
- 3 citations
Review
Published on 22 Mar 2022
Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.837632
- 7,367 views
- 12 citations
Original Research
Published on 21 Mar 2022
Association Between Drug Treatments and the Incidence of Liver Injury in Hospitalized Patients With COVID-19
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.799338
- 2,435 views
- 7 citations
Original Research
Published on 21 Mar 2022
Positive Association Between Fluoroquinolone Exposure and Tendon Disorders: A Nationwide Population-Based Cohort Study in Taiwan
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.814333
- 3,949 views
- 7 citations
Original Research
Published on 21 Mar 2022
Medication Regimen Complexity and Medication Burden Among Patients With Type 2 Diabetes Mellitus: A Retrospective Analysis
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.808190
- 5,405 views
- 20 citations
Original Research
Published on 21 Mar 2022
Consumption Trends of Antibiotics in Brazil During the COVID-19 Pandemic
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.844818
- 5,925 views
- 26 citations
Brief Research Report
Published on 11 Mar 2022
Identifying Patients at Risk of Acute Kidney Injury Among Medicare Beneficiaries With Type 2 Diabetes Initiating SGLT2 Inhibitors: A Machine Learning Approach
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.834743
- 3,756 views
- 4 citations
Review
Published on 09 Mar 2022
Diabetes, Metformin and the Clinical Course of Covid-19: Outcomes, Mechanisms and Suggestions on the Therapeutic Use of Metformin
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.784459
- 11,665 views
- 36 citations
Original Research
Published on 09 Mar 2022
Chronic Kidney Disease Progression Risk in Patients With Diabetes Mellitus Using Dihydropyridine Calcium Channel Blockers: A Nationwide, Population-Based, Propensity Score Matching Cohort Study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.786203
- 3,024 views
Brief Research Report
Published on 08 Mar 2022
Estimates of Paracetamol Poisoning in Brazil: Analysis of Official Records From 1990s to 2020
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.829547
- 3,964 views
- 4 citations
Original Research
Published on 07 Mar 2022
Prior Cardiovascular Treatments—A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.834898
- 2,541 views
- 2 citations
Original Research
Published on 03 Mar 2022
Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson’s Disease: A Nationwide Cohort Study
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.837890
- 5,625 views
- 39 citations
Original Research
Published on 25 Feb 2022
Structure-Activity Relationship (SAR) Model for Predicting Teratogenic Risk of Antiseizure Medications in Pregnancy by Using Support Vector Machine
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.747935
- 4,434 views
- 5 citations
Original Research
Published on 22 Feb 2022
Use of Drugs With Risk of Heart Rate-Related Problems is Common in Norwegian Dementia Patients Treated With Acetylcholinesterase Inhibitors: A Prevalence Study Based on the Norwegian Prescription Database
in Pharmacoepidemiology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.791578
- 2,412 views
- 1 citation